Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01372930

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01372930
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01372930. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
Intervention (Drug)
Etanercept
Intervention (Drug)
saline
Lead sponsor
Xijing Hospital (class: other)

Record details

Record id
cardio:ct-nct01372930
Content hash
48fd45cf030c2f53b7358957e035f1e0b4bdb4cba96fedef9cdb70799336534c